But an excess dose or extra ingredients may mean that you end up with side effects and symptoms beyond those already associated with GLP-1s, including nausea, vomiting, constipation, diarrhea and headaches are all common
In regards to the current GLP-1 medication shortage, Cutler said this is a topic and a struggle he deals with on a daily basis
The FDA approved it for type 2 diabetes management in 2022 and for weight control in November 2023
Prescription oral options exist too, formulated specifically to survive digestion, again with standardized dosing
For example, theyre contraindicated for women who are pregnant, those with a hypersensitivity to the drug, those with necrotizing pancreatitis, and patients with a family history of thyroid cancer